Medication-overuse headache
Authors:
- Irini SavidouISIrini Savidou
- Volker LimmrothVLVolker Limmroth
- 1 December 2005
- journal article
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 9 (6) , 430-435
Abstract
Medication-overuse headache (MOH) can be caused by almost all anti-headache drugs including analgesics, ergots, triptans, and combined preparations The prevalence of chronic daily headache (CDH) appears to be between 2% and 4% in the general population. Current epidemiologic studies suggest that MOH accounts for approximately 50% of these cases. The pathophysiology of MOH remains unclear. The only therapy is withdrawal from the overused substances. Prednisone decreases the duration of headache in the first days of withdrawal therapy. The only strategy to reduce the prevalence of MOH is to prevent the development of MOH in the first place by restriction of anti-headache drugs and constant education of patients.Keywords
This publication has 35 references indexed in Scilit:
- Medication Overuse Headache: Rates and Predictors for Relapse in a 4-year Prospective StudyCephalalgia, 2005
- Low‐Dose Tizanidine With Nonsteroidal Anti‐inflammatory Drugs for Detoxification From Analgesic Rebound HeadacheHeadache: The Journal of Head and Face Pain, 2002
- New Guidelines for the Management of Migraine in Primary CareCurrent Medical Research and Opinion, 2002
- Are There Predictive Factors for Long-Term Outcome after Withdrawal in Drug-Induced Chronic Daily Headache?Cephalalgia, 2001
- Successful Withdrawal From Analgesic Abuse in a Group of Youngsters With Chronic Daily HeadacheJournal of Child Neurology, 2001
- Prophylaxe und Therapie des medikamenteninduzierten DauerkopfschmerzesDer Schmerz, 1999
- Use of sumatriptan in Denmark in 1994–5: an epidemiological analysisof nationwide prescription dataBritish Journal of Clinical Pharmacology, 1997
- The Tromsø study: Frequency and predicting factors of analgesic drug use in a free-living population (12–56 years)Journal of Clinical Epidemiology, 1993
- Subcutaneous Sumatriptan in the Treatment of Headache During Withdrawal From Drug‐Induced HeadacheHeadache: The Journal of Head and Face Pain, 1991
- Amelioration of Ergotamine Withdrawal Symptoms With NaproxenHeadache: The Journal of Head and Face Pain, 1987